Addus EVP gets stock grant, sells shares for taxes

Addus HomeCare Corp executive Michael D. Wattenbarger reported both an equity grant and a small share sale.

Rhea-AI Filing Summary

Addus HomeCare Corp executive Michael D. Wattenbarger reported both an equity grant and a small share sale. On February 20, 2026, he acquired 3,117 shares of common stock as a grant with no purchase price, lifting his holdings to 10,913 shares.

The granted shares vest in three equal installments on each of February 20, 2027, 2028, and 2029, subject to continued service and change-in-control provisions. On February 23, 2026, he sold 577 shares at $114.91 per share in an open-market trade under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 10,336 directly owned shares.

Insider Trade Summary

Net Seller: 577 shares

Net Sell 2 txns

Insider WATTENBARGER MICHAEL D.

Role EVP, Chief Information Officer

Sold 577 shs ($66K)

Type	Security	Shares	Price	Value
Sale	Common Stock	577	$114.91	$66K
Grant/Award	Common Stock	3,117	$0.00	$0.00

Holdings After Transaction: Common Stock — 10,336 shares (Direct)

Footnotes (3)

1. F1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.
2. F2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
3. F3. Adoption date of referenced 10b5-1(c) plan is: 03/05/2025

FAQ

What insider transactions did Addus (ADUS) executive Michael Wattenbarger report?

Michael Wattenbarger reported a stock grant and a small sale. He received 3,117 Addus shares as an equity award, then sold 577 shares in an open-market trade under a Rule 10b5-1 plan to satisfy tax obligations from restricted stock vesting.

How many Addus (ADUS) shares did the executive acquire and at what cost?

He acquired 3,117 shares of Addus common stock at no purchase price as a grant. These shares were awarded as part of his compensation and will vest over time, rather than being bought in the market for cash.

When do Michael Wattenbarger’s new Addus (ADUS) shares vest?

The 3,117 granted Addus shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029. Vesting is subject to customary continued service conditions and potential acceleration if there is a change in control.

How many Addus (ADUS) shares did the executive sell and why?

He sold 577 shares of Addus common stock at $114.91 per share. The sale was made under a pre-established Rule 10b5-1 trading plan specifically to cover tax obligations due upon the vesting of restricted stock awards previously granted by Addus.

What is Michael Wattenbarger’s Addus (ADUS) share ownership after these transactions?

After the grant and subsequent sale, he directly owns 10,336 shares of Addus common stock. This figure reflects the 3,117-share award increasing his holdings, followed by the 577-share open-market sale executed under a Rule 10b5-1 plan.

What is the significance of the Rule 10b5-1 plan in this Addus (ADUS) Form 4?

The Rule 10b5-1 plan indicates the 577-share sale was pre-scheduled rather than discretionary. It was adopted on March 5, 2025, and the sale was executed to satisfy tax liabilities triggered by restricted stock vesting, helping separate the transaction from day-to-day trading decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WATTENBARGER MICHAEL D.

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		3,117(1)	A	$0	10,913	D
Common Stock	02/23/2026		S(2)(3)		577	D	$114.91	10,336	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.

2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

3. Adoption date of referenced 10b5-1(c) plan is: 03/05/2025

	/s/ Brian Poff, Attorney-in-Fact for Michael D. Wattenbarger	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.